John D Mccoy

Author:

John McCoy

ISBN #:

0819407712

Author:

John McCoy

ISBN #:

0826206042

Author:

John McCoy

ISBN #:

0787655813

Author:

John McCoy

ISBN #:

1930586701

Author:

John McCoy

ISBN #:

9004078509

Author:

John W. McCoy

ISBN #:

0892725273

Author:

John B. McCoy

ISBN #:

0786311126

Author:

John R. McCoy

ISBN #:

0398022038

US Patent:

7413773, Aug 19, 2008

Filed:

Jul 31, 2003

Appl. No.:

10/500442

Inventors:

John McCoy - Riverside CA, US
Deborah Elliott - Riverside CA, US

International Classification:

B05D 7/22

US Classification:

427231, 52306, 427232, 427235, 427240, 427181, 427183, 65395

Abstract:

Internally colored glass and glass-like blocks () and the method for making them. No means for coating the internal cavities () of clear glass and glass-like hollow blocks has been available. Color coating provides aesthetically pleasing structures. Internally colored glass and glass-like blocks may be used in building internal room dividers, providing colorful building designs and for providing color relief in heretofore otherwise drab structures.

US Patent:

20090007510, Jan 8, 2009

Filed:

Jul 9, 2008

Appl. No.:

12/217673

Inventors:

John McCoy - Riverside CA, US
Deborah Elliott - Riverside CA, US

International Classification:

E04C 1/42

US Classification:

52306

Abstract:

Internally colored glass and glass-like blocks () and the method for making them. No means for coating the internal cavities () of clear glass and glass-like hollow blocks has been available. Color coating provides aesthetically pleasing structures. Internally colored glass and glass-like blocks may be used in building internal room dividers, providing colorful building designs and for providing color relief in heretofore otherwise drab structures.

US Patent:

20130095484, Apr 18, 2013

Filed:

Oct 15, 2012

Appl. No.:

13/652463

Inventors:

Andy Ofer Goren - Newport Beach CA, US
John McCoy - Downey CA, US

International Classification:

C12Q 1/68
G01N 33/53
G01N 33/558
G01N 21/75

US Classification:

435 611, 435 25, 435 792, 435 71

Abstract:

Methods, processes, systems, and apparatuses are disclosed for predicting anti-androgen therapy response in the treatment of androgenetic alopecia based on a fluorometric assay and proteomics.

US Patent:

20130115180, May 9, 2013

Filed:

Nov 5, 2012

Appl. No.:

13/669435

Inventors:

Andy Ofer Goren - Newport Beach CA, US
John McCoy - Downey CA, US

International Classification:

A61K 8/60
A61K 31/7034
A01G 1/00
A61K 8/40
A61Q 17/04
B01J 19/12
A61N 5/06
A61K 31/24

US Classification:

424 60, 604 20, 2504921, 2504721, 47 581LS

Abstract:

Methods and compositions are disclosed for administering electromagnetic radiation (EMR), for therapeutic or cosmetic purposes, or for purposes of curing a polymeric material.

US Patent:

20130310730, Nov 21, 2013

Filed:

Jul 22, 2013

Appl. No.:

13/948090

Inventors:

John McCoy - Downey CA, US

Assignee:

Applied Biology, Inc. - Irvine CA

International Classification:

A61N 5/06
A61K 8/44
A61K 8/49

US Classification:

604 20, 424 60

Abstract:

Methods are disclosed for administering electromagnetic radiation (EMR), which may include filtering EMR from part of the EMR spectrum while allowing passage of EMR at a desired wavelength. A fluorescent component may be included, which absorbs EMR at one wavelength and emits EMR at the desired wavelength. Uses may include the treatment of acne. Pruritus may also be treated by allowing the passage to the skin of a particular UV wavelength from sunlight, which has an immunosuppressive effect, while protecting the skin from other harmful UV radiation.

US Patent:

20140023618, Jan 23, 2014

Filed:

Mar 15, 2013

Appl. No.:

13/843908

Inventors:

John McCoy - Downey CA, US

Assignee:

APPLIED BIOLOGY - Irvine CA

International Classification:

A61K 35/74
A61K 31/506
C12N 15/74

US Classification:

424 932, 424 934

Abstract:

A specific naturally occurring or genetically modified bacterial strain can be introduced into the hair follicle of patients suffering from androgenetic alopecia as to reduce the bioavailable extracellular testosterone and hence reduce the effect of androgens on the hair follicle.

US Patent:

39958337, Dec 7, 1976

Filed:

Jul 23, 1975

Appl. No.:

5/598440

Inventors:

Jack McLaughlin - Orange CA
John R. McCoy - Carson CA

International Classification:

E04H 1714

US Classification:

256 59

Abstract:

Removable guard rail stanchion apparatus comprises a clamping portion adapted for clamping to surfaces of a floor edge and a vertical stanchion post having a lower end releasably locked in a socket fixed to the clamping portion. The clamping portions includes larger and smaller diameter vertical tubes, the smaller diameter tube being slidably connected inside the larger diameter tube by an elongate axial screw. Horizontally projecting clamping member is fixed to each of the two tubes. Turning of the axial screw telescopes the tubes and thereby adjusts the spacing between the clamping members which bear against horizontal floor edge surfaces. A dished washer, through which the clamping force is applied, flattens to give a visual indication when sufficient clamping force has been applied, an angle is provided on at least one of the clamping members to fit over a floor edge corner to prevent twisting of the clamping portion relative to the floor edge. In a variation, the two tubes comprising the clamping portion are horizontally disposed, and the clamping members depend therefrom to enable clamping of vertical edge surfaces. The stanchion part may be locked into the clamping portion socket by a removable pin, by a friction lock, or by a socket pin which fits into an inverted L-shaped edge cut out on the post.

US Patent:

20220296486, Sep 22, 2022

Filed:

Jun 10, 2022

Appl. No.:

17/806363

Inventors:

- Cheyenne WY, US
John McCoy - Downey CA, US

International Classification:

A61K 8/49
A61P 17/14
A61K 8/04
A61K 8/67
A61K 8/44

Abstract:

Compositions and methods are disclosed herein for inducing (up-regulating) the expression of sulfotransferases in the hair follicles, e.g., the scalp. Increasing sulfotransferase is beneficial for metabolizing pro-drugs that require sulfonation to be activated, e.g., minoxidil sulfate is the active metabolite of minoxidil. A method for combining the compositions described herein with topical minoxidil to enhance minoxidil treatment for androgenetic alopecia is described. Additional methods and compositions include the use of retinoid X receptor agonists, retinoic acid receptor agonists, and nuclear receptor agonists in an RXR-NR heterodimer. Additional methods and compositions include the use of a topical solution containing an alkalinizing agent or an alkalinizing agent used with a penetration enhancer for up-regulating the sulfonating capacity of hair bearing skin, hair follicles, and/or keratinocyte cells. In addition, compositions and methods for increasing or decreasing the growth rate of hair follicles is disclosed by altering the intracellular pH. Additionally, methods for preparing a stable liposomal containing solution are described.